Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.350NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.350NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
B.1.304ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.304ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.304SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.304SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.304EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.304EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.304NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.304NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.315ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.315ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.315SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.315SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.315EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.315EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.315NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.315NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.516ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.516ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.516SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.516SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.516EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.516EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.516NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.516NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FK.1.4.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
FK.1.4.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
FK.1.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FK.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FK.1.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.13ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.13ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.13SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.13SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DR.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
DR.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
DR.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DR.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
DR.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DR.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DR.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.15ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.160.15ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used